HBIO
Harvard Bioscience Inc
Price:  
1.65 
USD
Volume:  
289,146.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO WACC - Weighted Average Cost of Capital

The WACC of Harvard Bioscience Inc (HBIO) is 8.9%.

The Cost of Equity of Harvard Bioscience Inc (HBIO) is 10.60%.
The Cost of Debt of Harvard Bioscience Inc (HBIO) is 6.65%.

Range Selected
Cost of equity 9.40% - 11.80% 10.60%
Tax rate 11.50% - 22.20% 16.85%
Cost of debt 6.30% - 7.00% 6.65%
WACC 8.1% - 9.7% 8.9%
WACC

HBIO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.2 1.24
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.40% 11.80%
Tax rate 11.50% 22.20%
Debt/Equity ratio 0.49 0.49
Cost of debt 6.30% 7.00%
After-tax WACC 8.1% 9.7%
Selected WACC 8.9%